£48.33

CRC Press Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 64 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 27 days • 27 data points (No recent data available)

Historical
Generating forecast...
£48.33 £45.40 £46.04 £46.68 £47.32 £47.96 £48.60 25 January 2026 31 January 2026 07 February 2026 13 February 2026 20 February 2026

Price Distribution

Price distribution over 27 days • 2 price levels

Days at Price
Current Price
4 days 23 days · current 0 6 12 17 23 £46 £48 Days at Price

Price Analysis

Most common price: £48 (23 days, 85.2%)

Price range: £46 - £48

Price levels: 2 different prices over 27 days

Description

State-of-the-Art Methods for Drug Safety Assessment Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
98% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)
96% match

Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£93.00 25 Jan 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
95% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.35 02 Mar 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
95% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£60.89 06 Mar 2026
Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)
94% match

Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.27 15 Feb 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
94% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£44.44 21 Feb 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
94% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£45.07 07 Mar 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
94% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 27 Feb 2026
Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)
94% match

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 22 Feb 2026
Handbook of Adaptive Designs in Pharmaceutical and Clinical Development
94% match

Handbook of Adaptive Designs in Pharmaceutical and Clinical Development

CRC Press

£45.77 12 Dec 2025
Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)
94% match

Statistics in Drug Research: Methodologies and Recent Developments: 10 (Chapman & Hall/CRC Biostatistics)

CRC Press

£239.20 10 Jan 2026
Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)
94% match

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)
94% match

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£105.00 10 Jan 2026
Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)
94% match

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

CRC Press

£64.98 23 Feb 2026
Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)
94% match

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

CRC Press

£63.78 19 Feb 2026
Adaptive Design Methods in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
94% match

Adaptive Design Methods in Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£42.31 09 Feb 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
94% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£42.31 28 Feb 2026
Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)
94% match

Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£86.76 27 Feb 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
93% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£49.90 18 Feb 2026
Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)
93% match

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Springer

£43.87 15 Feb 2026
CRC Press Statistical Design and Analysis of Stability Studies
93% match

CRC Press Statistical Design and Analysis of Stability Studies

CRC Press

£137.45 03 Mar 2026
Drug Safety Evaluation (Pharmaceutical Development Series)
93% match

Drug Safety Evaluation (Pharmaceutical Development Series)

Wiley

£148.58 09 Mar 2026
Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)
93% match

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£115.22 24 Feb 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
93% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.60 23 Feb 2026